Global Diabetic Neuropathy Market 2014-2018

Price :
Published : May-2014
No. of Pages : 55

Report Description

Diabetes is usually associated with progressive damage to the nervous system, which leads to disorders collectively known as diabetic neuropathy. Diabetic neuropathy is characterized by progressive damage to the neuronal myelin sheath, which slows down nerve conduction velocity. Axonal damage associated with diabetic neuropathy decreases nerve action potential below normal physiological level, which inhibits neuronal signal transmission. About 60 to 70 percent of the diabetic population develops neuropathy, with a considerable number of cases going undiagnosed during the initial years of progression. Disease management should start with the initial diagnosis of diabetes, from educating patients to giving them regular check-ups. Diabetic neuropathy treatment involves bringing blood glucose levels within the normal range to check for further nerve damage and also additional treatment to provide symptomatic relief. Alternative therapies, which help in managing pain, such as biofeedback, meditation, acupuncture or other relaxation techniques can also be used.

TechNavio’s analysts forecast the Global Diabetic Neuropathy market will grow at a CAGR of 8.41 percent over the period 2014-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the Global Diabetic Neuropathy market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of various pain management drugs administered to relieve the pain symptoms associated with diabetic neuropathy. The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the Global Diabetic Neuropathy market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

TechNavio’s report, the Global Diabetic Neuropathy Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas and the EMEA and APAC regions; it also covers the Global Diabetic Neuropathy market landscape and its growth prospects in the coming years.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Eli Lilly and Co.
  • Janssen Pharmaceuticals Inc.
  • Pfizer Inc.

Other Prominent Vendors

  • Actavis plc
  • Cephalon Inc.
  • MEDA Pharma GmbH & Co. KG

Key Market Driver

  • Increasing Global Diabetic Population.
  • For a full, detailed list, view our report.

Key Market Challenge

  • High Failure Rate in Clinical Trials.
  • For a full, detailed list, view our report.

Key Market Trend

  • Increasing R&D Activities.
  • For a full, detailed list, view our report.

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05. Introduction

06. Market Landscape
06.1 Market Overview
06.2 Market Size and Forecast
06.3 Five Forces Analysis

07. Geographical Segmentation

08. Buying Criteria

09. Market Growth Drivers

10. Drivers and their Impact

11. Market Challenges

12. Impact of Drivers and Challenges

13. Market Trends

14. Trends and their Impact

15. Vendor Landscape
15.1 Competitive Scenario
15.1.1 Key News
15.1.2 Mergers and Acquisitions
15.2 Market Share Analysis 2013
15.3 Other Prominent Vendors

16. Key Vendor Analysis
16.1 Pfizer Inc.
16.1.1 Business Overview
16.1.2 Key Information
16.1.3 SWOT Analysis
16.2 Eli Lilly and Company
16.2.1 Business Overview
16.2.2 Business Segmentation
16.2.3 Key Information
16.2.4 SWOT Analysis
16.3 Janssen Pharmaceuticals Inc.
16.3.1 Business Overview
16.3.2 Key Information
16.3.3 SWOT Analysis

17. Pipeline Analysis
17.1 Phase III Analysis
17.2 Phase II Analysis
17.3 Phase I Analysis
17.4 Discontinued Projects
17.5 Projects on Hold
17.6 Promising Pipeline Molecules
17.6.1 Phase III Promising Pipeline Molecules
17.6.2 Phase II Promising Pipeline Molecules
17.7 Other First-in-class Pipeline Molecules:

18. Other Reports in this Series

List of Exhibits:

Exhibit 1: Market Research Methodology
Exhibit 2: Global Diabetic Neuropathy Market 2013-2018 (US$ billion)
Exhibit 3: Global Diabetic Neuropathy Market by Geographical Segmentation 2013
Exhibit 4: Eli Lilly and Company: Business Segmentation
Exhibit 5: Diabetic Neuropathy Pipeline Snapshot 2013
Exhibit 6: Discontinued Pipeline Molecules on the basis of MOA

Filed in: Pharmaceutical, Therapeutics
Publisher : Infiniti Research Limited
More Reports
Title Price Buy Now

Global Hyaluronic Acid (HA) Market 2014-2018

Hyaluronic acid (HA) or glass acid is a naturally occurring non-sulfated glycosaminoglycan. It is present in the human body in the joints, eye cavity, and internal defense systems. It functions as a nutrient carrier, along with helping the tissues in retaining water. It is an integral part of the extracellular matrix and is found in the coverings around chondrocytes. HA is produced commercially by various processes, including extraction from animal tissues, bacterial production, and in-vitro production. Its major medical applications are viscosupplementation for osteoarthritis, ophthalmic, VUR, and dermal fillers. HA is commercially available in the form of single-injection cycle HA products, three-injection cycle HA products, and five-injection cycle HA products. TechNavio's analysts f......
$2500

Global Peptide Therapeutics Market 2014-2018

Peptides are amino acids sequences and among the most potent biologically active substances found in nature. Peptides are used to control, trigger, and maintain physiological processes in living beings. However, the use of peptides as therapeutic agents has always been difficult because of their inherent instability and incapability to cross cellular membranes. Peptides also entail the requirement of specific technology to tackle the extensive and challenging steps in their synthesis. Currently, there are more than 80 peptides marketed by various companies. These companies explore the probability of designing and engineering peptides that overcome their natural confines and allow these potent chemical entities to be used as therapeutic agents. TechNavio's analysts forecast the Global Pe......
$2500

Global Affinity Chromatography Reagents Market 2014-2018

Affinity chromatography is a method used in the examination of clinical samples with the help of high-performance liquid chromatography (HPLC) methods. Affinity chromatography is a liquid chromatography technique that helps purify and concentrate a substance from a mixture, and it also distinguishes what biological compounds bind to a particular substance. This technology is used by various end-users such as Biotechnology, Pharmaceutical, and Food and Beverages industries. TechNavio's analysts forecast the Global Affinity Chromatography Reagents market to grow at a CAGR of 9.27 percent over the period 2013-2018. Covered in this Report The report covers the present scenario and the growth prospects of the Global Affinity Chromatography Reagents market for the period 2014-2018. To c......
$2500

Global Proton Therapy Market 2014-2018

Proton therapy is a type of particle therapy which is used to treat cancer patients by means of proton beams irradiation. The main advantage of proton therapy is that while destroying the target malignant cells, it causes minimal damage to the surrounding cells. Proton therapy uses the ionization technique to inhibit cell proliferation. Protons move slowly through the body and interact with electrons and discharge energy. The MD Anderson Proton Therapy Center is the pioneer in this technology and also initiated the pencil beam proton therapy, which is also known as scanning beam and intensity modulated proton therapy. TechNavio's analysts forecast the Global Proton Therapy market to grow at a CAGR of 9.50 percent over the period 2013-2018. Covered in this Report This report covers......
$2500

Connected Health M2M Market in the US 2014-2018

Connected health M2M is a remote healthcare service delivery model that functions in an IT ecosystem. It enables the accessing and sharing of healthcare information and the analysis of healthcare data. It provides the management of clinical data, and communication and collaboration among all the stakeholders of the healthcare service ecosystem. Some of the major functions of connected health M2M services are the following: home monitoring, clinical monitoring, telemedicine, first responder connectivity, connected medical environment, clinical remote monitoring, assisted living and clinical trials, and healthcare asset management. TechNavio's analysts forecast the Connected Health M2M market in the US to grow at a CAGR of 34.34 percent over the period 2013-2018. Covered in this Report......
$2500

Global Medical Composite Materials Market 2014-2018

Medical composite materials are formed by mixing two or more components. These materials offer greater performance than individual components. Some of the major benefits of medical composite materials are high strength-to-weight ratio, excellent fatigue endurance, corrosion resistance, good impact resistance, and malleability. As a result of these properties, the Medical sector prefers medical composite materials compared to steel, plastic, and aluminum for producing custom-made and complex products. TechNavio's analysts forecast the Global Medical Composite Materials market to grow at a CAGR of 6.84 percent over the period 2013-2018. Covered in this Report The Global Medical Composite Materials market can be segmented into three, based on type: fiber composites, polymer metal com......
$2500

Global Database of the Top 1000 Pharmaceutical Producers – Company Names, Financial Performance, Key Executives, and Contact Details

This company database offers valuable information on top 1000 pharmaceutical producers in the world which makes the database an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key company information in readily accessible and clearly presented format. The database is essential for companies who want to find out more about the leading players on the market or to find and contact potential customers and partners. This vital database contains the following information about the companies (when available): Company name Financial data Number of employees Contact details (address, phone, fax, email, web site) Names of the key executives Reasons to buy: - Know who are the major companies operating in the global market ......
$1275

Global Database of the Top 1000 Biological Product Producers – Company Names, Financial Performance, Key Executives, and Contact Details

This company database offers valuable information on top 1000 biological product producers in the world which makes the database an invaluable resource for industry executives, marketing, sales and product managers, analysts, and other people looking for key company information in readily accessible and clearly presented format. The database is essential for companies who want to find out more about the leading players on the market or to find and contact potential customers and partners. This vital database contains the following information about the companies (when available): Company name Financial data Number of employees Contact details (address, phone, fax, email, web site) Names of the key executives Reasons to buy: - Know who are the major companies operating in the global mar......
$1275

Global H1N1 Vaccines Market 2014-2018

H1N1 influenza (zoonotic) is an infectious disease in humans caused by a variant of the swine H1N1 virus, known as H1N1v virus. The H1N1v virus is a contagious virus which infects nose, throat, and lungs. H1N1 virus is an RNA virus belonging to the Orthomyxoviridae family. Influenza A viruses infect different animal species such as humans, swine, birds, seals, and horses. Influenza A viruses can be subdivided on the basis of antigenicity of its surface glycoproteins neuraminidase and hemagglutinin. Hemagglutinin component is used by the virus to bind to host cell receptors. This facilitates viral entry into the host cell. Neuraminidase protein enzymatically cleaves terminal sialic acid residues from mucins, thereby allowing the virus to reach underlying cells in the respiratory tract. Elde......
$2500

Global Pancreatic Cancer Market 2014-2018

Pancreatic cancer is a malignant cells form in the tissues of pancreas. Based on the initiation, pancreatic cancer can be classified into exocrine pancreatic cancer and endocrine pancreatic cancer. When pancreatic cancer cells spread from the pancreas to other parts of the body, it is known as metastatic pancreatic order. The incidence and mortality rate of pancreatic cancer is higher in men than in women. SEER estimates that there were 46,420 new pancreatic cancer cases recorded in the US in 2014. It also estimated that 39,590 deaths occurred in the US in 2014 as a result of pancreatic cancer, accounting for 6.8 percent of the total cancer deaths in the US. TechNavio's analysts forecast the Global Pancreatic Cancer market to grow at a CAGR of 10.70 percent over the period 2013-2018. ......
$2500